CEA – MMab

Cea Mmab

IHC of CEA on an FFPE Colon Adenocarcinoma Tissue

Specification Sheets
Safety Data Sheet
Intended UseFor In Vitro Diagnostic Use
Summary and ExplanationCarcinoembryonic antigen (CEA) is a glycoprotein involved in cell adhesion. It is normally produced during fetal development, but the production of CEA stops before birth. Therefore, it is not usually present in the blood of healthy adults, although levels are raised in heavy smokers. CEA is synthesized during development in the fetal gut, and is re-expressed in increased amounts in Intestinal Carcinomas and several other tumors. CEA is employed essentially as a tool to assist in the distinction between Adenocarcinoma and Malignant Mesotheliomas of the epithelial type, along with other markers for mucosubstances such as Leu M1 and Ber-EP4. Another suggested use of CEA is the immunophenotyping of various Metastatic Adenocarcinomas as a means of identifying their origin.
Antibody TypeMouse MonoclonalCloneBSB-13
IsotypeIgG1/KReactivityParaffin, Frozen
LocalizationCytoplasmicControlColon, Colon Adenocarcinoma
PresentationCarcinoembryonic Antigen is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.
Catalog No.Antibody TypeDilutionVolume/QTY
BSB 5337PredilutedReady-To-Use3.0 ml
BSB 5338PredilutedReady-To-Use7.0 ml
BSB 5339PredilutedReady-To-Use15.0 ml
BSB 5340Concentrated1:250-1:10000.1 ml
BSB 5341Concentrated1:250-1:10000.5 ml
BSB 5342Concentrated1:250-1:10001.0 ml
BSB 5343Control Slides5
Note: For concentrated antibodies, please centrifuge prior to use to ensure recovery of all product.

Related products

Skip to content